Sahajanand Medical Technologies Limited
NSE: SMT
Business score
How strong the business is, in one number. The parts behind it are in Pro.
No business score for this company yet.
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹3,497 Cr
P/E ratio
53.4
P/B ratio
—
ROCE
11.4%
ROE
10.5%
Dividend yield
—
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Not enough price history yet.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
No answers for this company yet.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
Not enough filed accounts to run these checks yet.
Latest result
What the last results showed. Whether management kept its word is in Pro.
Results are expected soon.
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹3,497 Cr
- Prev close
- —
- 52w High
- —
- 52w Low
- —
- Enterprise value
- —
- Beta
- —
- Price CAGR 1y
- —
- Price CAGR 3y
- —
- Price CAGR 5y
- —
- Price CAGR 10y
- —
Ratios
- Return on assets
- 5.4%
- PEG ratio
- —
- P/E ratio
- 53.4
- P/B ratio
- —
- EV / EBITDA
- —
- Industry P/E
- —
- ROCE
- 11.4%
- ROCE 5y average
- 7.3%
- ROE
- 10.5%
- Debt / Equity
- 0.4
- Interest coverage
- 4.3
- Dividend yield
- —
- ROE 3y average
- 4.0%
- ROE last year
- 10.0%
Annual P&L
- Annual revenue
- ₹1,210 Cr
- Annual profit
- ₹69.0 Cr
- Operating margin
- 14.0%
- Net profit margin
- 5.7%
- EBITDA margin
- 14.1%
- Sales growth 3y
- —
- Sales growth 5y
- 15.5%
- Profit growth 3y
- —
- Profit growth 5y
- 27.0%
- EPS
- ₹6.4
- Sales growth TTM
- 18.0%
- Profit growth TTM
- 180.0%
- Dividend payout
- 0.0%
Quarter P&L
- Sales latest quarter
- ₹352 CrJun 2026 quarter
- Profit latest quarter
- ₹15.0 CrJun 2026 quarter
- YoY quarterly sales growth
- —
- YoY quarterly profit growth
- —
- OPM latest quarter
- 14.0%Jun 2026 quarter
Balance Sheet
- Book Value
- ₹69.6
- Face Value
- ₹1.0
- Total debt
- ₹306 Cr
- Total cash
- ₹75.0 Cr
- Borrowings
- ₹306 Cr
- Reserves / Equity
- 68.6
Cash Flow
- Operating cash flow
- ₹105 Cr
- Free cash flow
- ₹17.0 Cr
- FCF yield
- -0.2%
- Net cash flow
- -₹26.0 Cr
Shareholding
- Promoter holding
- 36.2%
- FII holding
- —
- DII holding
- —
- Public holding
- —
Peer comparison
| Company | P/E | Mkt cap ₹ Cr | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|
| Jio Platformsas of 23 Oct 2026 | 34.2 | 10.30L | 7,764 | 39,173 | 12.08% | ||
| Zetwerk Manufacturingas of 23 Oct 2026 | 25,582 | 4.05% | |||||
| Bonfiglioli Tranas of 23 Oct 2026 | 40.6 | 11,017 | 149 | 29.23% | 1,132 | 17.86% | 35.76% |
| EAAA Indiaas of 23 Oct 2026 | 39.4 | 10,765 | 125 | 414 | 26.58% | ||
| Paras Healthcareas of 23 Oct 2026 | 171.3 | 7,498 | 11.82% | ||||
| Tonbo Imagingas of 23 Oct 2026 | 80.1 | 4,010 | 12.68% | ||||
| Sahajanand Medi | 53.4 | 3,497 | 15.0 | 352 | 11.40% | ||
| Medianas of 23 Oct 2026 | 27.5 | 3,233 | 12.6 | 29.23% | 243 | 17.86% | 24.06% |
Competes with: Bonfiglioli Transmissions Limited, Poly Medicure Limited, Tonbo Imaging India Limited, Zetwerk Manufacturing Businesses Limited
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2026 |
|---|---|
| Sales | 352 |
| Expenses | 303 |
| Operating Profit | 49 |
| OPM % | 14.00% |
| Other Income | 3 |
| Interest | 7 |
| Depreciation | 20 |
| Profit before tax | 24 |
| Tax % | 38.00% |
| Net Profit | 15 |
| EPS in Rs | 1.44 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 589 | 690 | 902 | 1,025 | 1,210 |
| Expenses | 539 | 641 | 792 | 896 | 1,039 |
| Operating Profit | 49 | 48 | 110 | 129 | 171 |
| OPM % | 8.00% | 7.00% | 12.00% | 13.00% | 14.00% |
| Other Income | -39 | -19 | 7 | -5 | 8 |
| Interest | 20 | 22 | 19 | 21 | 24 |
| Depreciation | 35 | 38 | 64 | 63 | 74 |
| Profit before tax | -45 | -30 | 33 | 41 | 80 |
| Tax % | 60.00% | 61.00% | 122.00% | 38.00% | 14.00% |
| Net Profit | -72 | -49 | -7 | 25 | 69 |
| EPS in Rs | -8.14 | -5.25 | -1.26 | 2.01 | 6.44 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- —
- 5 years
- 15%
- 3 years
- —
- TTM
- 18%
Compounded profit growth
- 10 years
- —
- 5 years
- 27%
- 3 years
- —
- TTM
- 180%
Return on equity
- 10 years
- —
- 5 years
- —
- 3 years
- 4%
- Last year
- 10%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 10 | 10 | 10 |
| Reserves | 325 | 392 | 530 | 556 | 686 |
| Borrowings | 325 | 386 | 201 | 254 | 306 |
| Other Liabilities | 191 | 212 | 227 | 274 | 273 |
| Total Liabilities | 849 | 999 | 968 | 1,093 | 1,274 |
| Fixed Assets | 203 | 207 | 296 | 288 | 343 |
| CWIP | 60 | 122 | 13 | 6 | 9 |
| Investments | 0 | 0 | 6 | 5 | 59 |
| Other Assets | 586 | 669 | 652 | 794 | 863 |
| Total Assets | 849 | 999 | 968 | 1,093 | 1,274 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from Operating Activity | 46 | 17 | 41 | 74 | 105 |
| Cash from Investing Activity | -169 | -154 | -42 | -50 | -120 |
| Cash from Financing Activity | 212 | 109 | 13 | 6 | -12 |
| Net Cash Flow | 89 | -29 | 12 | 29 | -26 |
| Free Cash Flow | 18 | -76 | 2 | 26 | 17 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 116 | 86 | 55 | 85 | 79 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 158 | 125 | 87 | 94 | 86 |
| Inventory Days | 329 | 330 | 397 | 389 | 384 |
| Days Payable | 252 | 213 | 129 | 152 | 137 |
| Cash Conversion Cycle | 235 | 242 | 355 | 331 | 333 |
| Working Capital Days | 122 | -9 | 69 | 56 | 63 |
| ROCE % | 1.00% | 10.00% | 11.00% |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
No brick chart yet.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
No industry numbers filed for this company yet.
News
News and filings about Sahajanand Medical Technologies Limited. Open one to see why it matters.
No recent news for this company.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Medical Devices
- Industry
- Classification
- Medical Devices
- ISIN
- INE356Y01018
News impact
Big market events that reach Sahajanand Medical Technologies Limited, and how the effect spreads.
No recent market events reach this company.
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
No dividends, splits or big trades on record.
Documents
Annual reports, results presentations and earnings calls, straight from the source.
No documents on record yet.
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.